Oncologist

Dr. Ankur Bahl is a distinguished cancer specialist with over 15 years of rich experience in the field. His academic journey includes an MBBS from Maulana Azad Medical College, Delhi, followed by an MD in Medicine. He further specialized in Medical Oncology with a degree from AIIMS, New Delhi. Dr. Bahl also completed a course on Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance at the University of Oxford, UK.

His clinical expertise covers a wide range of oncology areas, including Immunotherapy, targeted therapies in combination with Chemotherapy, Hormonal Therapy, Supportive, and Palliative Care. Notably, Dr. Bahl is recognized as the lead author of the largest real-world Indian data on targeted therapy, particularly in Head & Neck cancer, Acute Myeloid Leukemia Treatment, and Human Papillomavirus trends in the Indian population.

Dr. Bahl's contributions extend beyond clinical practice. He has founded innovative oncology educational platforms and networks at both international and national levels. These include Evidence-based debates in oncology, Live Oncology Tumor boards, Master Classes, and workshops in oncology. Before joining FMRI in Gurugram, he held the position of Director of Medical Oncology and Hematology at Max Hospital, Saket. His distinguished career has seen him associated with prestigious organizations like Rajiv Gandhi Cancer Institute and Research Centre, as well as Maulana Azad Medical College. Dr. Ankur Bahl is known for his unwavering commitment to advancing the field of oncology.